Cryo-Cell International Inc (CCEL) KPIs and segments
Close on Nov 13, 2026Market cap $39.10MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Cryo-Cell International's business
Cryo-Cell International's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
Cryo-Cell International's fiscal year ends November 30 — Q3 FY26 = CQ3 2026 (calendar quarter).
| Add to chart | Metric | Q3 FY26 CQ3 2026 | Q2 FY26 CQ2 2026 | Q1 FY26 CQ1 2026 | Q4 FY25 CQ4 2025 | Q3 FY25 CQ3 2025 | Q2 FY25 CQ2 2025 | Q1 FY25 CQ1 2025 | Q4 FY24 CQ4 2024 | Q3 FY24 CQ3 2024 | Q2 FY24 CQ2 2024 | Q1 FY24 CQ1 2024 | Q4 FY23 CQ4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Umbilical Cord Blood and Cord Tissue Stem Cell Service($M) | 7.65 | 7.72 | 7.64 | 7.82 | 7.82 | 7.87 | 7.87 | 7.84 | 7.95 | 7.97 | 7.81 | 7.79 | |
Public Cord Blood Banking($M) | 0.14 | 0.05 | 0.00 | 0.00 | 0.00 | 0.04 | 0.08 | 0.16 | 0.12 | 0.04 | 0.04 | 0.08 | |
PrepaCyte CB($M) | 0.04 | 0.01 | 0.04 | 0.02 | 0.00 | 0.01 | 0.02 | 0.03 | 0.00 | 0.04 | 0.00 | 0.00 | |
Processing and Storage Fees($M) | 7.65 | 7.72 | 7.64 | 7.82 | 7.82 | 7.87 | 7.87 | 7.84 | 7.95 | 7.97 | 7.81 | 7.79 | |
Public Banking Revenue($M) | 0.14 | 0.05 | 0.00 | 0.00 | 0.00 | 0.04 | 0.08 | 0.16 | 0.12 | 0.04 | 0.04 | 0.08 | |
Product Revenue($M) | 0.04 | 0.01 | 0.04 | 0.02 | 0.00 | 0.01 | 0.02 | 0.03 | 0.00 | 0.04 | 0.00 | 0.00 | |
Umbilical Cord Blood and Cord Tissue Stem Cell Service($M) | 2.20 | 1.26 | 0.84 | 0.49 | 2.03 | 1.65 | 1.24 | 0.02 | 1.54 | 1.52 | 1.06 | -12.2 | |
PrepaCyte CB($M) | 0.02 | 0.01 | 0.03 | 0.01 | -0.00 | 0.00 | 0.01 | 0.01 | -0.01 | 0.02 | -0.03 | -0.01 | |
Public Cord Blood Banking($M) | -0.02 | -0.07 | -0.10 | -4.46 | -0.13 | -0.16 | -0.19 | -0.15 | -0.14 | -0.14 | -0.21 | -3.92 | |
Umbilical Cord Blood and Cord Tissue Stem Cell Service($M) | 6.22 | 6.16 | 6.10 | 6.21 | 6.15 | 6.22 | 6.16 | 6.52 | 6.09 | 6.14 | 6.02 | 6.04 | |
PrepaCyte CB($M) | 0.02 | 0.01 | 0.03 | 0.01 | -0.00 | 0.01 | 0.01 | 0.02 | -0.00 | 0.03 | -0.02 | -0.00 | |
Public Cord Blood Banking($M) | -0.02 | -0.07 | -0.10 | -0.11 | -0.13 | -0.16 | -0.19 | -0.15 | -0.14 | -0.14 | -0.21 | -0.18 | |
Umbilical Cord Blood and Cord Tissue Stem Cell Service($M) | 61.4 | 59.8 | 59.9 | 60.8 | 57.9 | 59.2 | 59.0 | 59.3 | 57.3 | 56.9 | 56.0 | 59.3 | |
Public Cord Blood Banking($M) | 0.81 | 0.79 | 0.80 | 0.80 | 5.16 | 5.16 | 5.24 | 5.28 | 5.47 | 5.54 | 5.57 | 5.28 | |
PrepaCyte CB($M) | 0.09 | 0.12 | 0.14 | 0.14 | 0.09 | 0.06 | 0.12 | 0.14 | 0.15 | 0.11 | 0.13 | 0.14 | |
Remaining performance obligations (RPO)($M) | 64.0 | 62.8 | 61.5 | 59.6 | 58.4 | 57.2 | 55.0 | 53.5 | 52.0 | ||||
12 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-10-09.
See a number that looks wrong?